| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $265,962,464 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K07CA230182 | Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men | 000 | 5 | NIH | 6/30/2022 | $138,440 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01AI141576 | Mathematical modeling to optimize rotavirus vaccination in sub-Saharan Africa | 000 | 4 | NIH | 11/26/2021 | $129,779 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH115031 | Reward System Function as a Potential Mediator of the Impact of Stress on Psychopathology: A Computational Neuroimaging Study | 000 | 5 | NIH | 4/20/2022 | $516,693 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM129584 | Ubiquitin-dependent mitochondrial quality control | 000 | 4 | NIH | 2/8/2022 | $303,062 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA211909 | A novel sulforaphane cancer preventionmechanism | 002 | 5 | NIH | 6/9/2022 | $29,637 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA211909 | A novel sulforaphane cancer preventionmechanism | 000 | 5 | NIH | 1/26/2022 | $333,392 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA211909 | A novel sulforaphane cancer preventionmechanism | 001 | 5 | NIH | 1/27/2022 | $17,367 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS110635 | Mechanism of Inflammatory Related Brain Dysfunction after Spinal Cord Injury | 000 | 4 | NIH | 3/29/2022 | $431,648 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM129584 | Ubiquitin-dependent mitochondrial quality control | 001 | 4 | NIH | 7/21/2022 | $33,677 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL142290 | Chemo-mechanical signaling in atrial myocytes | 001 | 4 | NIH | 5/31/2022 | $66,170 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL142290 | Chemo-mechanical signaling in atrial myocytes | 000 | 4 | NIH | 12/9/2021 | $595,520 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI141900 | Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine | 001 | 4 | NIH | 5/4/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI141900 | Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine | 000 | 4 | NIH | 1/20/2022 | $693,310 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | H2A39973 | Telehealth Network Grant Program | 00 | 3 | HRSA | 7/14/2022 | $300,000 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL146377 | Malaria variant surface antigen expression and vulnerability to disease in Malian children with Hemoglobin C trait | 000 | 4 | NIH | 6/10/2022 | $347,585 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K24AR076445 | Development of orthopaedic surgeon-scientist expertise in patient-oriented research | 000 | 3 | NIH | 4/18/2022 | $118,479 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08NS114039 | Impact of human anti-NMDA receptor antibodies on glutamate receptor signaling, calcium mobilization, and hippocampal neuronal circuits in autoimmune encephalitis | 000 | 4 | NIH | 8/1/2022 | $191,250 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | 90REMM0001 | Rehabilitation Interventions Based on Accurate Assessments with Combined Home-Hospital Rehabilitation | 00 | 3 | ACL | 8/30/2022 | $924,885 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HG010571 | Microbiome-Based Diagnostics: Stakeholder Perceptions and Implications for the Regulatory Framework | 000 | 4 | NIH | 6/3/2022 | $309,000 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MH127822 | Imaging triheteromeric NMDAR distribution and trafficking | 000 | 2 | NIH | 6/15/2022 | $192,739 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA256557 | A Multi-pronged Computational Approach to Advance Kinase Drug Discovery | 000 | 2 | NIH | 3/30/2022 | $344,952 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01AI163413 | Integrating multi-omics data: Modeling biomarkers and mechanisms to reduce bacterial vaginosis recurrence | 000 | 2 | NIH | 5/20/2022 | $92,865 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA233441 | Impact of concomitant chemotherapy on HIV resistance to cART and reservoir size | 002 | 4 | NIH | 6/7/2022 | -$6,746 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR073181 | Development of Pharmacological Treatment of Osteochondromas | 001 | 4 | NIH | 8/5/2022 | $27,532 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA233441 | Impact of concomitant chemotherapy on HIV resistance to cART and reservoir size | 001 | 4 | NIH | 1/13/2022 | $33,734 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR073181 | Development of Pharmacological Treatment of Osteochondromas | 000 | 4 | NIH | 2/14/2022 | $275,319 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA233441 | Impact of concomitant chemotherapy on HIV resistance to cART and reservoir size | 000 | 4 | NIH | 12/30/2021 | $303,595 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32CA154274 | Training Grant in Cancer Biology | 000 | 11 | NIH | 7/15/2022 | $507,175 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | P01AI125181 | Pathogenesis of E. coli and Shigella infections in human enteroid models | 002 | 7 | NIH | 8/19/2022 | $2,032,323 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167947 | Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4 | 001 | 1 | NIH | 9/13/2022 | $386,250 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167947 | Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4 | 001 | 1 | NIH | 9/13/2022 | -$386,250 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167947 | Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4 | 000 | 1 | NIH | 1/26/2022 | $386,250 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UH3DA047685 | Circuitry-Guided Smoking Cessation in Schizophrenia | 000 | 3 | NIH | 2/4/2022 | $410,568 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21DE031888 | Impact of SARS-CoV-2 mediated salivary gland dysfunction on secreted salivary antimicrobial peptides and the risk for oral opportunistic infections | 000 | 1 | NIH | 3/18/2022 | $231,750 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA261934 | Mobile element mutagenesis as a driver of human cancers | 000 | 1 | NIH | 8/2/2022 | $353,419 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM140822 | Extracellular miRNAs, innate immunity, and critical illness | 001 | 2 | NIH | 6/22/2022 | $38,625 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM140822 | Extracellular miRNAs, innate immunity, and critical illness | 000 | 2 | NIH | 2/23/2022 | $347,625 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | H1740194 | Healthy Tomorrows Partnership for Children Program | 01 | 2 | HRSA | 6/22/2022 | $30,671 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | H1740194 | Healthy Tomorrows Partnership for Children Program | 00 | 2 | HRSA | 2/15/2022 | $19,306 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167367 | Mechanisms of protection against shigellosis in children | 000 | 1 | NIH | 6/9/2022 | $778,440 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08HS028854 | Optimizing Implementation of Multiplex Molecular Panel Testing to Reduce Diagnostic Error | 000 | 1 | AHRQ | 5/10/2022 | $147,180 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K23EY032525 | Identification of Anterior Segment Structural Biomarkers in Glaucoma Following Pediatric Cataract Using Ultrasound Biomicroscopy | 000 | 1 | NIH | 7/28/2022 | $236,357 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM127523 | Regulatory and Functional Mechanisms in hERG Ion Channels | 001 | 4 | NIH | 7/20/2022 | $28,509 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM127523 | Regulatory and Functional Mechanisms in hERG Ion Channels | 000 | 4 | NIH | 2/18/2022 | $256,556 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33HD103066 | Long-term neurocognitive outcomes of HIV-exposed uninfected children | 000 | 3 | NIH | 6/30/2022 | $639,691 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01AR080377 | HIP fracture Accelerated surgical TreaTment And Care tracK-2 (HIP ATTACK-2) trial | 000 | 1 | NIH | 7/29/2022 | $1,004,029 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F32MH130106 | Mechanisms of cell adhesion molecule LRRTM2 in basal and potentiated synaptic signaling | 000 | 1 | NIH | 9/1/2022 | $67,582 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG3DA056039 | PTPRD phosphatase inhibitors for stimulant use disorders | 000 | 1 | NIH | 6/24/2022 | $1,453,896 |
| | 2022 | 2022 | UNIVERSITY OF MARYLAND | 220 ARCH ST RM 02148 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R56DE030423 | Targeting PI3Kalpha beta and the ErbB family of protein-tyrosine kinases in cisplatin-resistant head and neck squamous cell carcinomas (HNSCC) | 000 | 1 | NIH | 8/9/2022 | $376,310 |
|
